title: Should red blood cell transfusion be individualized? No.
authors.affiliation: Department of Intensive Care, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. lars.broksoe.holst@regionh.dk.
authors.forename: Lars B
authors.initials: LB
authors.lastname: Holst
authors.affiliation: Division of General Internal Medicine, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA. jeffrey.carson@rutgers.edu.
authors.forename: Jeffrey L
authors.initials: JL
authors.lastname: Carson
authors.affiliation: Department of Intensive Care, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. anders.perner@regionh.dk.
authors.forename: Anders
authors.initials: A
authors.lastname: Perner
mesh_terms: D015415:Biomarkers / Q000097:blood; D001930:Brain Injuries / Q000628:therapy; D006348:Cardiac Surgical Procedures / Q000592:standards; D003422:Critical Care / Q000592:standards*; D016638:Critical Illness; D017707:Erythrocyte Transfusion / Q000379:methods / Q000592:standards*; D055317:Evidence-Based Practice / Q000592:standards; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D017202:Myocardial Ischemia / Q000628:therapy; D017410:Practice Guidelines as Topic; D057285:Precision Medicine / Q000379:methods / Q000592:standards*; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data
chemical_list: D015415:Biomarkers; D006454:Hemoglobins